Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
17%(1 trials)

Phase Distribution

Ph not_applicable
9
90%
Ph phase_2
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(6)
Terminated(2)
Other(1)

Detailed Status

Completed6
Withdrawn2
Enrolling by invitation1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (10.0%)
N/A9 (90.0%)

Trials by Status

completed660%
enrolling_by_invitation110%
unknown110%
withdrawn220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10